 | Synovial Sarcoma Treatment Sales Market By Current Industry Status,Growth Opportunities, Top Key Players, Target Audience And Forecast To 2022
www.marketwatch.com - September 21 at 5:22 AM |
 | Does The Adaptimmune Therapeutics plc (NASDAQ:ADAP) Share Price Fall With The Market?
finance.yahoo.com - September 16 at 9:01 AM |
 | Philadelphia Immuno-oncology company Imvax hires CEO
www.bizjournals.com - September 10 at 5:25 AM |
 | Adaptimmune's SPEAR T-cells targeting MAGE-A4 an Orphan Drug in U.S.
seekingalpha.com - September 10 at 5:25 AM |
| United States Orphan Drug Designation for Treatment of Soft Tissue Sarcomas Granted to SPEAR T-cells Targeting MAGE-A4
finance.yahoo.com - September 10 at 5:25 AM |
 | Adaptimmune Therapeutics PLC - (NASDAQ:ADAP) Receives Consensus Recommendation of "Hold" from Brokerages
www.americanbankingnews.com - September 7 at 12:47 PM |
| $4.25 Million in Sales Expected for Adaptimmune Therapeutics PLC - (NASDAQ:ADAP) This Quarter
www.americanbankingnews.com - September 5 at 4:02 AM |
| Financial Review: Biogen (NASDAQ:BIIB) versus Adaptimmune Therapeutics (NASDAQ:ADAP)
www.americanbankingnews.com - September 4 at 4:16 AM |
| Zacks: Analysts Anticipate Adaptimmune Therapeutics PLC - (NASDAQ:ADAP) Will Post Earnings of -$0.33 Per Share
www.americanbankingnews.com - September 3 at 10:17 AM |
 | BRIEF-Adaptimmune And Noile-Immune Announce Pact To Develop Spear T-Cell Products For Cancer
www.msn.com - August 28 at 12:31 PM |
| Adaptimmune and Noile-Immune Announce Agreement to Develop SPEAR T-Cell Products expressing IL-7 and CCL19 as a next-generation treatment for cancer patients
finance.yahoo.com - August 27 at 9:04 AM |
| Allogene Therapeutics Appoints Rafael G. Amado, M.D. as Executive Vice President of Research and Development and Chief Medical Officer
www.marketwatch.com - August 5 at 10:59 AM |
| Edited Transcript of ADAP earnings conference call or presentation 1-Aug-19 12:00pm GMT
finance.yahoo.com - August 4 at 7:25 PM |
| Adaptimmune Therapeutics plc (ADAP) CEO James Noble on Q2 2019 Results - Earnings Call Transcript
seekingalpha.com - August 3 at 6:42 PM |
| Adaptimmune Reports Second Quarter 2019 Financial Results and Business Update
finance.yahoo.com - August 1 at 10:25 AM |
| New Executive Team Announced at Adaptimmune
finance.yahoo.com - August 1 at 10:25 AM |
| Adaptimmune to Report Second Quarter 2019 Financial Results and Business Update on Thursday, August 1, 2019
finance.yahoo.com - July 29 at 11:43 PM |
| Adaptimmune Starts SPEARHEAD-1 Trial with ADP-A2M4 SPEAR T-cells for patients with Synovial Sarcoma or MRCLS
finance.yahoo.com - July 25 at 11:32 AM |
| Adaptimmune up 10% on promise of low-dose radiation to improve SPEAR T-cell therapy
seekingalpha.com - July 22 at 7:13 PM |
| Adaptimmune Has Initiated a Radiation Sub-Study to Enhance Antitumor Activity Seen With ADP-A2M4 in Collaboration with The MD Anderson Cancer Center
finance.yahoo.com - July 22 at 8:55 AM |
| How Should Investors Feel About Adaptimmune Therapeutics plc's (NASDAQ:ADAP) CEO Pay?
finance.yahoo.com - July 18 at 6:50 PM |
| Adaptimmune Starts the SURPASS Clinical Trial with its first Next-Generation SPEAR T-cells Targeting MAGE‑A4 to Enhance Antitumor Responses
finance.yahoo.com - July 18 at 9:07 AM |
| Adaptimmune Therapeutics PLC (ADAP) Upgraded to Strong Buy: Here's Why
finance.yahoo.com - July 9 at 6:23 PM |
| Synovial Sarcoma Therapeutics Pipeline to Witness Remarkable Growth due to Increased Number of Pipeline Candidates by Drug Developers
www.marketwatch.com - July 2 at 6:20 PM |
| Is Adaptimmune Therapeutics plc (ADAP) Going to Burn These Hedge Funds?
finance.yahoo.com - June 30 at 8:37 AM |
| New chief at Adaptimmune
seekingalpha.com - June 27 at 6:27 PM |
| 5 More Stocks Priced Under $10 With Massive Implied Upside
www.msn.com - June 1 at 8:45 AM |
| Those Who Purchased Adaptimmune Therapeutics (NASDAQ:ADAP) Shares A Year Ago Have A 72% Loss To Show For It
finance.yahoo.com - May 28 at 6:02 PM |
| Here’s What Hedge Funds Think About Adaptimmune Therapeutics plc (ADP)
finance.yahoo.com - May 10 at 8:47 AM |
| Adaptimmune up 6% premarket on positive ADP-A2M4 data in cancer
seekingalpha.com - May 6 at 7:23 PM |
| Significant Clinical Progress as Adaptimmune Announces Responses with ADP-A2M4 in Synovial Sarcoma and Antitumor Activity in Other Solid Tumors
finance.yahoo.com - May 6 at 8:42 AM |
| Adaptimmune Reports First Quarter 2019 Financial Results
finance.yahoo.com - May 6 at 8:42 AM |
| Adaptimmune to Present Data Demonstrating that its Off-the-shelf Process Produces T-cells from Stem Cells that Respond to Cancer Targets with a SPEAR TCR at ASGCT Meeting
finance.yahoo.com - May 2 at 8:47 AM |
| Adaptimmune to Provide Clinical and Business Update on Monday May 6th, 2019
finance.yahoo.com - May 1 at 8:34 AM |
| Adaptimmune Announces Oral Presentation of Allogeneic SPEAR T-cell Program at 2019 ASGCT Meeting
finance.yahoo.com - April 18 at 7:14 PM |
| Adaptimmune Presents Safety Data with Evidence of Tumor Necrosis in One Patient from ADP-A2AFP Study at American Association for Cancer Research (AACR) Meeting
finance.yahoo.com - April 2 at 9:25 AM |
| Adaptimmune Presents Preclinical Data for its Next Generation SPEAR T-cell Targeting MAGE-A4 at the American Association for Cancer Research (AACR) Annual Meeting
finance.yahoo.com - April 1 at 8:51 AM |
| Does Adaptimmune Therapeutics plc (NASDAQ:ADAP) Have A Particularly Volatile Share Price?
finance.yahoo.com - March 15 at 7:08 PM |
| Edited Transcript of ADAP earnings conference call or presentation 27-Feb-19 1:00pm GMT
finance.yahoo.com - February 28 at 8:51 AM |
 | CORRECTING and REPLACING -- Adaptimmune Reports Fourth Quarter / Full Year 2018 Financial Results and Business Update
globenewswire.com - February 27 at 7:02 PM |
| Adaptimmune Reports Fourth Quarter / Full Year 2018 Financial Results and Business Update
finance.yahoo.com - February 27 at 8:43 AM |
| Should You Worry About Adaptimmune Therapeutics plc’s (NASDAQ:ADAP) CEO Salary Level?
finance.yahoo.com - February 7 at 6:24 PM |
| Adaptimmune to Report Fourth Quarter / Full Year 2018 Financial Results and Business Update on Wednesday, February 27, 2019
finance.yahoo.com - February 7 at 8:40 AM |
| The Unknown Biotech Play that Could Deliver 400% Returns, or Much More
www.marketwatch.com - February 1 at 8:50 AM |
| Adaptimmune Therapeutics PLC (ADAP) Upgraded to Buy: Here's What You Should Know
finance.yahoo.com - January 28 at 6:05 PM |
| Adaptimmune Therapeutics PLC (ADAP) Upgraded to Buy: Here's What You Should Know
finance.yahoo.com - January 28 at 6:05 PM |
 | Adaptimmune Therapeutics PLC (ADAP)
www.zacks.com - January 8 at 6:03 PM |
| Dose Escalation in Liver Cancer Study with ADP-A2AFP (AFP) SPEAR T-cells and Moving to Expansion Phase in ADP-A2M10 (MAGE-A10) Lung Cancer Study after Favorable Safety Reviews
finance.yahoo.com - January 7 at 8:32 AM |
| What Percentage Of Adaptimmune Therapeutics plc (NASDAQ:ADAP) Shares Do Insiders Own?
finance.yahoo.com - January 2 at 5:17 PM |
| Adaptimmune tech chief to depart next month; shares down 12%
seekingalpha.com - December 12 at 4:03 PM |
